Equillium, Inc.
General ticker "EQ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $28.7M (TTM average)
Equillium, Inc. follows the US Stock Market performance with the rate: 35.2%.
Estimated limits based on current volatility of 5.3%: low 0.81$, high 0.90$
Factors to consider:
- Total employees count: 44 (+22.2%) as of 2023
- Top business risk factors: Economic downturns and volatility, Labor/talent shortage/retention, Intellectual property risks, Cybersecurity threats, Supply chain disruptions
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.42$, 1.22$]
- 2025-12-31 to 2026-12-31 estimated range: [0.41$, 1.19$]
Financial Metrics affecting the EQ estimates:
- Positive: with PPE of -2.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -82.22 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 74.45 > 63.39
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term EQ quotes
Long-term EQ plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.76MM | $36.08MM | $41.09MM |
| Operating Expenses | $77.83MM | $50.61MM | $49.36MM |
| Operating Income | $-62.08MM | $-14.52MM | $-8.27MM |
| Non-Operating Income | $-0.35MM | $1.77MM | $0.56MM |
| Interest Expense | $1.05MM | $0.49MM | $0.00MM |
| R&D Expense | $60.60MM | $37.04MM | $37.43MM |
| Income(Loss) | $-62.43MM | $-12.76MM | $-7.71MM |
| Taxes | $0.00MM | $0.58MM | $0.36MM |
| Profit(Loss)* | $-62.43MM | $-13.34MM | $-8.07MM |
| Stockholders Equity | $31.94MM | $22.57MM | $19.06MM |
| Assets | $78.42MM | $50.53MM | $25.60MM |
| Operating Cash Flow | $-8.73MM | $-21.78MM | $-19.03MM |
| Capital expenditure | $0.28MM | $0.05MM | $0.09MM |
| Investing Cash Flow | $18.68MM | $-4.76MM | $13.81MM |
| Financing Cash Flow | $-1.22MM | $-9.23MM | $0.16MM |
| Earnings Per Share** | $-1.85 | $-0.38 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.